Sub-analysis of lymphocyte subsets in major types of MSAs DM-ILD (> 10% of total study population) showed a significantly lower total lymphocyte count, CD3+ cell count and CD3+CD4+ cell count (all P < 0.05) (Table 4). This evidence concerns the gene CD4 and interstitial lung disease.